Cargando…

Downregulated Platelet miR-1233-5p in Patients with Alzheimer’s Pathologic Change with Mild Cognitive Impairment is Associated with Aβ-Induced Platelet Activation via P-Selectin

MicroRNAs (miRNAs) have been proposed as a promising biomarker for various diseases including Alzheimer’s disease (AD). More attention has recently been focused on the diagnosis and treatment at earlier stage of mild cognitive impairment (MCI) for preventing its progression to AD. To identify potent...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Bo Kyung, Kim, Min Hee, Lee, Sang Yoon, Son, Sang Joon, Hong, Chang Hyung, Jung, Yi-Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357133/
https://www.ncbi.nlm.nih.gov/pubmed/32485903
http://dx.doi.org/10.3390/jcm9061642
_version_ 1783558643300433920
author Lee, Bo Kyung
Kim, Min Hee
Lee, Sang Yoon
Son, Sang Joon
Hong, Chang Hyung
Jung, Yi-Sook
author_facet Lee, Bo Kyung
Kim, Min Hee
Lee, Sang Yoon
Son, Sang Joon
Hong, Chang Hyung
Jung, Yi-Sook
author_sort Lee, Bo Kyung
collection PubMed
description MicroRNAs (miRNAs) have been proposed as a promising biomarker for various diseases including Alzheimer’s disease (AD). More attention has recently been focused on the diagnosis and treatment at earlier stage of mild cognitive impairment (MCI) for preventing its progression to AD. To identify potential pathologic markers for Aβ(+)MCI (Alzheimer’s pathologic change with MCI), we investigated miRNA expression profiles in the platelets from patients with Aβ(+)MCI, in comparison with those from Aβ(−)MCI (Non-Alzheimer’s pathologic change with MCI) and CNI (cognitively normal individuals). We found that let-7i-5p, miR-125a, miR-1233-5p, and miR-6787-5p were significantly downregulated, while miR-6880-5p expression was upregulated. Of these, only miR-1233-5p was significantly downregulated by Aβ treatment in both human platelets and their precursor megakaryocytes (MEG-01 cells). We explored the role of miRNAs by using miRNA mimics or inhibitors, and found that the diminished level of miR-1233-5p was associated with Aβ-induced increase in the expression of P-selectin and cell adhesion to fibronectin. Our results further indicated that Aβ-induced increase in platelet/MEG adhesion to fibronectin is likely mediated via P-selectin. In conclusion, this study suggests the downregulation of platelet-derived miR-1233-5p as a pathologic marker for Aβ(+)MCI.
format Online
Article
Text
id pubmed-7357133
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73571332020-07-23 Downregulated Platelet miR-1233-5p in Patients with Alzheimer’s Pathologic Change with Mild Cognitive Impairment is Associated with Aβ-Induced Platelet Activation via P-Selectin Lee, Bo Kyung Kim, Min Hee Lee, Sang Yoon Son, Sang Joon Hong, Chang Hyung Jung, Yi-Sook J Clin Med Article MicroRNAs (miRNAs) have been proposed as a promising biomarker for various diseases including Alzheimer’s disease (AD). More attention has recently been focused on the diagnosis and treatment at earlier stage of mild cognitive impairment (MCI) for preventing its progression to AD. To identify potential pathologic markers for Aβ(+)MCI (Alzheimer’s pathologic change with MCI), we investigated miRNA expression profiles in the platelets from patients with Aβ(+)MCI, in comparison with those from Aβ(−)MCI (Non-Alzheimer’s pathologic change with MCI) and CNI (cognitively normal individuals). We found that let-7i-5p, miR-125a, miR-1233-5p, and miR-6787-5p were significantly downregulated, while miR-6880-5p expression was upregulated. Of these, only miR-1233-5p was significantly downregulated by Aβ treatment in both human platelets and their precursor megakaryocytes (MEG-01 cells). We explored the role of miRNAs by using miRNA mimics or inhibitors, and found that the diminished level of miR-1233-5p was associated with Aβ-induced increase in the expression of P-selectin and cell adhesion to fibronectin. Our results further indicated that Aβ-induced increase in platelet/MEG adhesion to fibronectin is likely mediated via P-selectin. In conclusion, this study suggests the downregulation of platelet-derived miR-1233-5p as a pathologic marker for Aβ(+)MCI. MDPI 2020-05-29 /pmc/articles/PMC7357133/ /pubmed/32485903 http://dx.doi.org/10.3390/jcm9061642 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lee, Bo Kyung
Kim, Min Hee
Lee, Sang Yoon
Son, Sang Joon
Hong, Chang Hyung
Jung, Yi-Sook
Downregulated Platelet miR-1233-5p in Patients with Alzheimer’s Pathologic Change with Mild Cognitive Impairment is Associated with Aβ-Induced Platelet Activation via P-Selectin
title Downregulated Platelet miR-1233-5p in Patients with Alzheimer’s Pathologic Change with Mild Cognitive Impairment is Associated with Aβ-Induced Platelet Activation via P-Selectin
title_full Downregulated Platelet miR-1233-5p in Patients with Alzheimer’s Pathologic Change with Mild Cognitive Impairment is Associated with Aβ-Induced Platelet Activation via P-Selectin
title_fullStr Downregulated Platelet miR-1233-5p in Patients with Alzheimer’s Pathologic Change with Mild Cognitive Impairment is Associated with Aβ-Induced Platelet Activation via P-Selectin
title_full_unstemmed Downregulated Platelet miR-1233-5p in Patients with Alzheimer’s Pathologic Change with Mild Cognitive Impairment is Associated with Aβ-Induced Platelet Activation via P-Selectin
title_short Downregulated Platelet miR-1233-5p in Patients with Alzheimer’s Pathologic Change with Mild Cognitive Impairment is Associated with Aβ-Induced Platelet Activation via P-Selectin
title_sort downregulated platelet mir-1233-5p in patients with alzheimer’s pathologic change with mild cognitive impairment is associated with aβ-induced platelet activation via p-selectin
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357133/
https://www.ncbi.nlm.nih.gov/pubmed/32485903
http://dx.doi.org/10.3390/jcm9061642
work_keys_str_mv AT leebokyung downregulatedplateletmir12335pinpatientswithalzheimerspathologicchangewithmildcognitiveimpairmentisassociatedwithabinducedplateletactivationviapselectin
AT kimminhee downregulatedplateletmir12335pinpatientswithalzheimerspathologicchangewithmildcognitiveimpairmentisassociatedwithabinducedplateletactivationviapselectin
AT leesangyoon downregulatedplateletmir12335pinpatientswithalzheimerspathologicchangewithmildcognitiveimpairmentisassociatedwithabinducedplateletactivationviapselectin
AT sonsangjoon downregulatedplateletmir12335pinpatientswithalzheimerspathologicchangewithmildcognitiveimpairmentisassociatedwithabinducedplateletactivationviapselectin
AT hongchanghyung downregulatedplateletmir12335pinpatientswithalzheimerspathologicchangewithmildcognitiveimpairmentisassociatedwithabinducedplateletactivationviapselectin
AT jungyisook downregulatedplateletmir12335pinpatientswithalzheimerspathologicchangewithmildcognitiveimpairmentisassociatedwithabinducedplateletactivationviapselectin